Eton Pharmaceuticals (ETON)
(Delayed Data from NSDQ)
$18.34 USD
-0.12 (-0.65%)
Updated Sep 19, 2025 03:59 PM ET
After-Market: $18.29 -0.05 (-0.27%) 7:58 PM ET
5-Strong Sell of 5 5
F Value A Growth D Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, Eton Pharmaceuticals, Inc. has a market cap of $495.05M, which represents its share price of $18.46 multiplied by its outstanding shares number of 26.82M. As a small-cap company, ETON's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
ETON 18.34 -0.12(-0.65%)
Will ETON be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ETON based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ETON
Eton Pharmaceuticals, Inc. (ETON) Reports Q2 Loss, Tops Revenue Estimates
Eton Pharmaceuticals, Inc. (ETON) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
ETON: What are Zacks experts saying now?
Zacks Private Portfolio Services
Eton Pharmaceuticals (ETON) Upgraded to Buy: Here's Why
Eton Pharmaceuticals (ETON) Is a Great Choice for 'Trend' Investors, Here's Why
Eton Pharmaceuticals, Inc. (ETON) Q1 Earnings Lag Estimates
Other News for ETON
MACD Bullish Signal Line Cross appears for ETON after 0.65% move
Is ETON coiling for a breakout? Bollinger Band Squeeze shows up after gaining 4.41%
Bollinger Band Squeeze appears for ETON after 0.68% move
New Uptrend appears for ETON after 1.24% move
ETON Hosts Virtual Meeting on September 25